Lilly, Novartis, Merck Chase Larger Stake In Japan Drug Market
This article was originally published in PharmAsia News
Executive Summary
Japan's drug companies are under attack by Eli Lilly, Novartis, Merck and other global firms seeking a greater share of the world's second-largest buyer of pharmaceuticals